HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Nonprofit Pharmaceutical Companies

506.075

-10.940-2.12%

Number of Gainers:9

Number of Losers:21

Number of Flat:3

PE:- -

High:516.490

Open:516.490

Low:500.597

Close:517.015

Volume:149.97M

Turnover:4.87B

Market Cap:324.25B

Float Cap:288.12B

Loading ...

Evening Market Wrap: Cancer Vaccine Breakthrough Sends US Pharma Soaring, SK Hynix Announces Massive Buyback

Kintor Pharma-B Reports Interim Results with Narrowed Net Loss of RMB 75.6 Million

Kintor Net Loss Narrows 9% to RMB 75.8 Million in 1H FY26; Revenue Rises to RMB 52 Million

Kintor Pharmaceutical H1 Revenue RMB 52 Million

THOMSON REUTERS

Global First mRNA Cancer Vaccine Hits Major Milestone, 3D Medicines Jumps 17% on International Revaluation

Akeso (SEHK:9926) Could Be 47% Undervalued As China Approves Ivonescimab Use

Simply Wall St.

KEYMED BIO-B (02162) Announces Proposed RMB Share Issuance for STAR Market Listing

Keymed Biosciences Plans RMB Share Listing on Shanghai STAR Market

KeyMed Biosciences - no Application Made to Regulatory Authorities for RMB Share Issue as of Aug 19, 2026

THOMSON REUTERS

KeyMed Biosciences - Proposes RMB Share Issue for Sci-Tech Board Listing

THOMSON REUTERS

KeyMed Biosciences H1 Revenue RMB 617.068 Million

THOMSON REUTERS

US Treasury Turmoil Batters Tech Stocks While Banks Steady Hong Kong Market

CARsgen Therapeutics (SEHK:2171) Stock Carries Premium Valuation Despite Ongoing Losses

Simply Wall St.

Zylox-Tonbridge Files HKEX Next-Day Disclosure Return, Lifts Share Capital by 250,000 Shares

Hengrui Pharma's First-Half Results Unveil Strategic Shifts: From Innovative Drugs to NewCo Expansion

SinoMab BioScience Schedules Board Meeting to Review Interim Results

BAIYUNSHAN PH Secures Regulatory Approval for Citicoline Sodium Injection New Dosage Strengths

Penalty Finalized for Nanxin Pharmaceutical Over Disclosure Violations, Affected Investors Invited to Register Claims

China's AI-Driven Drug Discovery Sector Poised for Clinical Breakthroughs and Commercial Growth, Analyst Says

Shinva Medical Secures Class III Medical Device Certification for Single-Use Plasma Surgical Electrode

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/BK1574/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1574","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","market":"HK","secType":"PLATE","nameCN":"Nonprofit Pharmaceutical Companies","latestPrice":506.0749,"timestamp":1787299686774,"preClose":517.0147,"halted":0,"volume":149966252,"delay":0,"changeRate":-0.02116,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Market Closed","change":-10.939819,"latestTime":"08-21 16:00:00","open":516.49023,"high":516.49023,"low":500.59692,"amount":4865243342.5,"amplitude":0.030741,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1787535000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1787275800000,1787284800000],[1787288400000,1787299200000]],"pbRate":4.109535,"peRate":-81.157718,"turnoverRate":0.005372,"increases":11,"decrements":20,"flats":2,"marketCap":324245256080,"floatMarketCap":288118014384},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","high":516.49023,"amplitude":0.030741,"preClose":517.0147,"low":500.59692,"pbRate":"4.109535","latestPrice":506.0749,"volume":149966252,"delay":0,"open":516.49023,"prevYearClose":556.26263,"prevWeekClose":518.327,"prevMonthClose":473.313,"prevQuarterClose":453.519,"fiveDayClose":518.327,"twentyDayClose":498.407,"sixtyDayClose":542.586,"secType":"PLATE","market":"HK","turnoverRate":0.005372,"peRate":-81.157718,"marketCap":324245256080,"floatMarketCap":288118014384,"timestamp":1787299686774,"nameCN":"Nonprofit Pharmaceutical Companies"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1574\",,,,undefined,":{"bkCode":"BK1574","up":9,"down":21,"flat":3},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1574\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1170810384","title":"Evening Market Wrap: Cancer Vaccine Breakthrough Sends US Pharma Soaring, SK Hynix Announces Massive Buyback","url":"https://stock-news.laohu8.com/highlight/detail?id=1170810384","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1170810384?lang=en_us&edition=fundamental","pubTime":"2026-08-19 22:40","pubTimestamp":1787150452,"startTime":"0","endTime":"0","summary":"Here are the key evening market developments investors need to know. NDRC Advances 'Six Networks' Infrastructure Plan On August 19, the National Development and Reform Commission (NDRC) held a...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159646","03130","02827","BK1147","BK1574","09939","BK1515","399300","07233","03188","83130","BK1161","02846","159982","82846","83188","159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178952366","title":"Kintor Pharma-B Reports Interim Results with Narrowed Net Loss of RMB 75.6 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1178952366","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178952366?lang=en_us&edition=fundamental","pubTime":"2026-08-19 22:40","pubTimestamp":1787150416,"startTime":"0","endTime":"0","summary":"Kintor Pharma-B (09939) has unveiled its interim financial results for the period ending June 30, 2026, showcasing a notable surge in revenue from RMB 6 million in the prior-year period to RMB 52...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","09939","BK1574","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660242429","title":"Kintor Net Loss Narrows 9% to RMB 75.8 Million in 1H FY26; Revenue Rises to RMB 52 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2660242429","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660242429?lang=en_us&edition=fundamental","pubTime":"2026-08-19 22:33","pubTimestamp":1787149999,"startTime":"0","endTime":"0","summary":"Kintor net loss narrows 9% to RMB 75.8 million in 1H FY26; revenue rises to RMB 52 millionKintor posted revenue of RMB 52 million, up 766.7% year over year, driven by global sales of its KOSHIN cosmet","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nNDL7xt97N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1515","BK1161","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660429211","title":"Kintor Pharmaceutical H1 Revenue RMB 52 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2660429211","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660429211?lang=en_us&edition=fundamental","pubTime":"2026-08-19 22:32","pubTimestamp":1787149978,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nPLXXDMDQT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","BK1515","09939","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150133670","title":"Global First mRNA Cancer Vaccine Hits Major Milestone, 3D Medicines Jumps 17% on International Revaluation","url":"https://stock-news.laohu8.com/highlight/detail?id=1150133670","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150133670?lang=en_us&edition=fundamental","pubTime":"2026-08-19 22:22","pubTimestamp":1787149350,"startTime":"0","endTime":"0","summary":"On August 19, a landmark moment arrived for tumor immunotherapy. Moderna and Merck announced that their phase III clinical trial, INTerpath-001, evaluating the tumor neoantigen mRNA vaccine mRNA-4157...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","159938","159646","BK1161","09939","BK1515","01244"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660244894","title":"Akeso (SEHK:9926) Could Be 47% Undervalued As China Approves Ivonescimab Use","url":"https://stock-news.laohu8.com/highlight/detail?id=2660244894","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660244894?lang=en_us&edition=fundamental","pubTime":"2026-08-19 22:20","pubTimestamp":1787149244,"startTime":"0","endTime":"0","summary":"Akeso (SEHK:9926) is back in focus after China’s National Medical Products Administration approved ivonescimab plus chemotherapy as a first-line treatment for advanced squamous non-small cell lung cancer.\nSee our latest analysis for Akeso.\nDespite the positive ivonescimab news, Akeso’s share price has come under pressure, with the stock down 12.54% over the past week and 21.18% year to date. At the same time, the 3 year total shareholder return of 185.76% and 5 year total shareholder return...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9926/akeso-shares/news/akeso-sehk9926-could-be-47-undervalued-as-china-approves-ivo","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9926/akeso-shares/news/akeso-sehk9926-could-be-47-undervalued-as-china-approves-ivo","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU2476274308.USD","IE00BPRC5H50.USD","LU0417516571.SGD","LU0348767384.USD","LU2778985437.USD","09926","LU2399975544.HKD","LU2476274720.SGD","LU0348827113.USD","LU1961090484.USD","LU1794554557.SGD","LU0417516902.SGD","LU2488822045.USD","LU0417516738.SGD","BK1574","LU1720050803.USD","LU0634319403.HKD","LU0348735423.USD","BK1161","LU0348784397.USD","LU0348766576.USD","IE00B543WZ88.USD","KURE","LU0348825331.USD","IE00B5MMRT66.SGD","LU0348783233.USD","LU0540923850.HKD","LU0561508036.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189925275","title":"KEYMED BIO-B (02162) Announces Proposed RMB Share Issuance for STAR Market Listing","url":"https://stock-news.laohu8.com/highlight/detail?id=1189925275","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1189925275?lang=en_us&edition=fundamental","pubTime":"2026-08-19 21:40","pubTimestamp":1787146814,"startTime":"0","endTime":"0","summary":"KEYMED BIO-B (02162) has announced that its board of directors resolved on August 19, 2026, to propose the issuance of ordinary shares denominated and traded in Renminbi, with a planned listing on...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IPOS","MCNHmain","CYB","UCmain","KSTR","BK1161","CNHmain","BK1587","BK1574","BK1583","MUCmain","02162"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660425003","title":"Keymed Biosciences Plans RMB Share Listing on Shanghai STAR Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2660425003","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660425003?lang=en_us&edition=fundamental","pubTime":"2026-08-19 21:32","pubTimestamp":1787146323,"startTime":"0","endTime":"0","summary":"Keymed Biosciences plans RMB share listing on Shanghai STAR MarketKeymed Biosciences’ board on Aug. 19, 2026 backed a plan to issue RMB-denominated ordinary shares for listing on Shanghai’s Sci-Tech B","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nNDL75lXNG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1587","BK1161","BK1583","02162"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660425012","title":"KeyMed Biosciences - no Application Made to Regulatory Authorities for RMB Share Issue as of Aug 19, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2660425012","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660425012?lang=en_us&edition=fundamental","pubTime":"2026-08-19 21:31","pubTimestamp":1787146294,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nFWN44G0G8:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","02162","BK1574","BK1587","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660250934","title":"KeyMed Biosciences - Proposes RMB Share Issue for Sci-Tech Board Listing","url":"https://stock-news.laohu8.com/highlight/detail?id=2660250934","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660250934?lang=en_us&edition=fundamental","pubTime":"2026-08-19 21:31","pubTimestamp":1787146294,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nFWN44G0G8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02162","BK1583","BK1587","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660425459","title":"KeyMed Biosciences H1 Revenue RMB 617.068 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2660425459","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660425459?lang=en_us&edition=fundamental","pubTime":"2026-08-19 21:23","pubTimestamp":1787145836,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nPLXHNXCKZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1583","BK1587","02162","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171659413","title":"US Treasury Turmoil Batters Tech Stocks While Banks Steady Hong Kong Market","url":"https://stock-news.laohu8.com/highlight/detail?id=1171659413","media":"Stock News","labels":["economic"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171659413?lang=en_us&edition=fundamental","pubTime":"2026-08-19 20:59","pubTimestamp":1787144382,"startTime":"0","endTime":"0","summary":"Global technology equities faced a brutal selloff that originated on Wall Street, with the Philadelphia Semiconductor Index (SOX) plunging 4.98% overnight as all 30 constituent stocks closed lower,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"economic","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HXXD.SI","ISHG","BK1214","BK1161","MWNmain","LU0918141705.HKD","LU2778985437.USD","LU0417516738.SGD","TLTW","VUSV","EQRR","LU1961090484.USD","01548","TMF","LU0143863198.USD","BK4535","LU0348816934.USD","LU2294711473.HKD","LU1960683339.HKD","IEI","XIACY","WAMA","LU0117841782.USD","BK1575","TYO","TBT","BK4504","BK4561","LU0823413660.USD","00300","LU1813983027.USD","HK0000306701.USD","HK0000320223.HKD","LU1956131251.USD","LU2039709279.SGD","LU0572944931.SGD","LU0531970944.HKD","VCSH","LU1719994722.HKD","VLUE","LU0143863784.USD","LU1770034418.SGD","UTWY","IE00B3M56506.USD","LU0039217434.USD","LU0441854154.USD","LU0650527681.SGD","01810","LU2399975544.HKD","BK1607","UBmain","LU1808992512.USD","BK1588","VALQ","HK0000165453.HKD","BK4588","LU2476274720.SGD","LU1770036033.HKD","HK0000306685.HKD","LU0594300419.USD","SG9999001093.SGD","LU0823397285.USD","XBIL","BK1193","VGIT","BND","BK1574","BSV","LU2257852520.SGD","LU0797268264.HKD","BK1576","LU0540923850.HKD","BOXX","LU1868837565.USD","LU0588546209.SGD","LU1251922891.USD","LU0169518387.USD","BK1610","LU0320764599.SGD","LU0499858602.USD","BK1589","LU2152927971.USD","LU0359201612.USD","LU0823038988.USD","LU0052750758.USD","LU1023057109.AUD","LU2226246903.HKD","LU0823397103.USD","81810","TIP","09688","SHV","LU2087589342.USD","UTRE","HMOP","LU0499858438.USD","BK1615","ZNmain","LU0449509016.USD","LU0823040885.USD","LIAJ","LU0823039010.USD","LU2097828714.EUR","LU0327786744.USD","LU0164880469.USD","LU1105468828.SGD","IE0034224299.USD","LU0823426480.USD","TLH","LU0823041008.USD","VGLT","LU0214875030.USD","LU0871576103.HKD","IEF","MUB","SGOV","LU0456827905.SGD","LU0634319403.HKD","LU0348827113.USD","IE0032431581.USD","LU0307460666.USD","LU0210526637.USD","KCAI","LU0345776255.USD","FLGV","LU1880383440.USD","LU0531971595.HKD","LU0823413587.USD","LU0449515922.USD","LU1794554557.SGD","JPST","BBIB","UBT","MUNX","TSYW","LU0605514214.HKD","LU1807302812.USD","TNmain","01907","CGVV","DBND","BNDW","LU0594300179.USD","DRGN","BWZ","BKDV","LU0348825331.USD","LU1282648689.USD","ZTmain","LU1993786604.SGD","USVN","LU1323998911.USD","LU0084288322.USD","UTHY","LU0700851271.USD","VTV","LU2097828557.USD","ABEQ","LU0149721374.USD","EDV","CIVG","BBSB","ROPE","AGG","BIL","HYG","LU0359201885.HKD","LU0593848301.USD","TBIL","BK1523","LU0244354667.USD","LU0675040207.SGD","LU0611395673.USD","TFJL","LU2097828474.EUR","SG9999003461.SGD","LU0345775950.USD","LU1303224171.USD","LU0348814723.USD","MINT","BOND","LU1481107354.HKD","VCIT","PY","BITC","LU0211977185.USD","TBJL","LU1981816686.USD","BK1141","GOLY","LU0054450605.USD","LU1328277881.USD","LU0164865239.USD","LU2476274308.USD","BK4550","LU1188198961.HKD","LU1868838027.USD","LU0823426308.USD","LU2097828631.EUR","UFIV","LU0417516902.SGD","LU0463099449.HKD","GBIL","LU2097828805.USD","USHY","VXUS","ZBmain","ZFmain","LU0231483743.USD","LQD","LU0456846285.SGD","ZROZ","LU0235996351.USD","NGHT","LU0051755006.USD","BBLB","LU0708995583.HKD","BK1502","SCHO","LU0561508036.HKD","HK0000320264.USD","LU0326950275.SGD","SPVM","HK0000286598.CNH","MTNmain","TALV","BK4581","MIUmain","BK1521","IE00B0169L03.USD","PRF","SHY","LU0254981946.USD","SWP","IGOV","SG9999002463.SGD","GOVT","LU0348735423.USD","LU0164872284.USD","BK1618","BK1506","BK1583","LU0314109678.HKD","TLTX","TLTI","LU2488822045.USD","VGSH","TLT","LU0918141887.USD","BK4585","LU0359202008.SGD","DFLV","LU1880383366.USD","LU1720050803.USD","BK1110","MYCN","BWX","VMAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660431424","title":"CARsgen Therapeutics (SEHK:2171) Stock Carries Premium Valuation Despite Ongoing Losses","url":"https://stock-news.laohu8.com/highlight/detail?id=2660431424","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660431424?lang=en_us&edition=fundamental","pubTime":"2026-08-19 20:27","pubTimestamp":1787142431,"startTime":"0","endTime":"0","summary":"CARsgen Therapeutics Holdings closed at HK$14.90 today after a choppy few months in which the stock has slipped about 15% over 90 days. Yet behind the weak chart, the latest half year numbers point to one issue that matters most for you as a shareholder. The balance sheet and valuation strain is now the key tension between short term sentiment and long term promise.\nRevenue for the first half of 2026 came in at ¥61.9 million, while the company still reported a net loss of ¥66.7 million. With...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2171/carsgen-therapeutics-holdings-shares/news/carsgen-therapeutics-sehk2171-stock-carries-premium-valuatio","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2171/carsgen-therapeutics-holdings-shares/news/carsgen-therapeutics-sehk2171-stock-carries-premium-valuatio","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1585","BK4139","02171","BK1574","LENZ","BK1161","BK1587","BK4007","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660702428","title":"Zylox-Tonbridge Files HKEX Next-Day Disclosure Return, Lifts Share Capital by 250,000 Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2660702428","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660702428?lang=en_us&edition=fundamental","pubTime":"2026-08-19 20:25","pubTimestamp":1787142331,"startTime":"0","endTime":"0","summary":"Zylox-Tonbridge files HKEX next-day disclosure return, lifts share capital by 250,000 sharesZylox-Tonbridge filed a next-day disclosure return covering a transfer of 250,000 H Shares from treasury on ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nNDL5sPjqv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","02190","BK1583","BK1100","BK1587"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178000037","title":"Hengrui Pharma's First-Half Results Unveil Strategic Shifts: From Innovative Drugs to NewCo Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=1178000037","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178000037?lang=en_us&edition=fundamental","pubTime":"2026-08-19 20:08","pubTimestamp":1787141307,"startTime":"0","endTime":"0","summary":"On August 19, Hengrui Pharma (01276) released its 2026 semi-annual report. During the reporting period, the company achieved operating revenue of RMB 15.456 billion, with product sales revenue of RMB...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1255011170.USD","LU1969619763.USD","LU2097828557.USD","159992","LU2097828474.EUR","LU1781817850.SGD","LU1655091616.SGD","LU0359202008.SGD","BK0028","LU2097828714.EUR","LU2148510915.USD","LU1997245177.USD","LU1820825898.SGD","LNGR","LU2097828805.USD","BK0188","IBBQ","LU1064130708.USD","LU2097828631.EUR","BK0183","BK0239","600276","LU2543165471.USD","LU2328871848.SGD","BK0060","LU2580892789.USD","BK1191","01276","06978","LU2488822045.USD","BK0012","LU0359201885.HKD","LU1328615791.USD","MEDX","LU1146622755.USD","LU1997244956.HKD","LU1997245094.SGD","BK0196","LU0405327494.USD","LU2580892862.HKD","LU2289578879.USD","BK1161","LU0359201612.USD","LU1580142542.USD","LU1064131003.USD","BK1574","LU1023057109.AUD","LU0405327148.USD","LU2495084118.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660447344","title":"SinoMab BioScience Schedules Board Meeting to Review Interim Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2660447344","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660447344?lang=en_us&edition=fundamental","pubTime":"2026-08-19 19:04","pubTimestamp":1787137487,"startTime":"0","endTime":"0","summary":"SinoMab BioScience schedules board meeting to review interim resultsSinoMab BioScience set a board meeting for Aug. 31, 2026 to review the group’s interim results for the six months ended June 30, 202","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nNDL4cbBb6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03681","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197235257","title":"BAIYUNSHAN PH Secures Regulatory Approval for Citicoline Sodium Injection New Dosage Strengths","url":"https://stock-news.laohu8.com/highlight/detail?id=1197235257","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197235257?lang=en_us&edition=fundamental","pubTime":"2026-08-19 16:36","pubTimestamp":1787128594,"startTime":"0","endTime":"0","summary":"BAIYUNSHAN PH (00874) has announced that its majority-owned subsidiary, Guangzhou Baiyunshan Tiansin Pharmaceutical Co., Ltd., recently received the Drug Supplement Application Approval Notice from...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1521","01477","BK0070","BK1606","BK1515","00874","BK0012","BK1574","600332","BK0196","BK0239","BK1197","BK0183","BK0188","BK0175","BK0096","BK1191","BK0097","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144883245","title":"Penalty Finalized for Nanxin Pharmaceutical Over Disclosure Violations, Affected Investors Invited to Register Claims","url":"https://stock-news.laohu8.com/highlight/detail?id=1144883245","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1144883245?lang=en_us&edition=fundamental","pubTime":"2026-08-19 16:20","pubTimestamp":1787127636,"startTime":"0","endTime":"0","summary":"Nanxin Pharmaceutical has officially received its penalty after an investigation into annual report disclosure violations, and eligible investors are now being encouraged to register for potential...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01477","BK1191","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117891527","title":"China's AI-Driven Drug Discovery Sector Poised for Clinical Breakthroughs and Commercial Growth, Analyst Says","url":"https://stock-news.laohu8.com/highlight/detail?id=1117891527","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1117891527?lang=en_us&edition=fundamental","pubTime":"2026-08-19 16:18","pubTimestamp":1787127519,"startTime":"0","endTime":"0","summary":"China Merchants Securities has released a research report indicating that AI-powered drug discovery has entered the clinical validation phase, with a commercial surge on the horizon. As the...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VTHR","BK1574","BK1564","BK0010","BK0028","BK0183","ARTY","BK0012","BK1191","AIPO","AGIX","600999","BK0276","01477","QTOC","BK1147","06099","CHAT","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128583126","title":"Shinva Medical Secures Class III Medical Device Certification for Single-Use Plasma Surgical Electrode","url":"https://stock-news.laohu8.com/highlight/detail?id=1128583126","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128583126?lang=en_us&edition=fundamental","pubTime":"2026-08-19 15:48","pubTimestamp":1787125716,"startTime":"0","endTime":"0","summary":"Shinva Medical Instrument Co., Ltd. (600587.SH) announced that its subsidiary, Shinva Surgical Instruments Co., Ltd., has recently received the Medical Device Registration Certificate issued by...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IEIH","MDEV","BK0251","BK0188","HART","BK1100","PTH","BK1583","RSPH","BK1574","AGNG","09996","600587","159883","LGHT","BK0028","LNGR","MEDX","GDOC"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":15,"pageCount":6,"totalSize":285,"code":"91000000","status":"200"}]}}